ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Virtus LifeSci Biotech Products ETF
100.71
-2.9227
-2.82%
盘后:
100.71
0.0000
0.00%
16:10 EDT
成交量:
1.23万
成交额:
125.26万
市值:
1.26亿
市盈率:
- -
高:
103.68
开:
103.68
低:
100.71
收:
103.63
52周最高:
110.05
52周最低:
70.30
股本:
125.00万
流通股本:
125.00万
量比:
1.19
换手率:
0.99%
股息:
- -
股息率:
- -
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
概念
没有相关数据
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻资讯
纳微科技与智翔金泰签署战略合作协议
智通财经
·
10/12
美股异动 | 美国临床阶段生物制药公司Retension Pharmaceuticals(RTSN.US)登陆美股市场 开盘后股价跌超10%
智通财经
·
10/10
韩国1至9月生物制药出口额创纪录,达66亿美元
智通财经
·
10/08
韩国1至9月生物制药出口额创纪录,达66亿美元
环球市场播报
·
10/08
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/BBP"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":100.7072,"timestamp":1791921600000,"preClose":103.6299,"halted":0,"volume":12317,"hourTrading":{"tag":"盘后","latestPrice":100.7072,"preClose":100.7072,"latestTime":"16:10 EDT","volume":6,"amount":604.2432,"timestamp":1791922204896,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02820325022025502,"floatShares":1250004,"shares":1250004,"eps":0,"marketStatus":"盘后交易","change":-2.9227,"latestTime":"10-13 19:27:45 EDT","open":103.68,"high":103.68,"low":100.705,"amount":1252625,"amplitude":0.028708,"askPrice":136.8,"askSize":100,"bidPrice":87.8,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791936000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":103.6299,"sharesOutstanding":600004,"nav":104.84,"aum":131050460.64,"bidAskSpread":0.002428,"preHourTrading":{"tag":"盘前","latestPrice":103.6299,"preClose":103.6299,"latestTime":"07:01 EDT","volume":1,"amount":103.6299,"timestamp":1791889277032,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":100.7072,"preClose":100.7072,"latestTime":"16:10 EDT","volume":6,"amount":604.2432,"timestamp":1791922204896,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.187181,"impliedVol":0.2467,"impliedVolPercentile":0.6972},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1250004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.187181,"shares":1250004,"dividePrice":0,"high":103.68,"amplitude":0.028708,"preClose":103.6299,"low":100.705,"week52Low":70.303,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":100.7072,"eps":0,"divideRate":0,"volume":12317,"delay":0,"ttmEps":0,"open":103.68,"prevYearClose":79.9149,"prevWeekClose":104.7564,"prevMonthClose":105.5872,"prevQuarterClose":105.5872,"fiveDayClose":100.9666,"twentyDayClose":101.1392,"sixtyDayClose":96.3276},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674342870","title":"纳微科技与智翔金泰签署战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2674342870","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674342870?lang=zh_cn&edition=fundamental","pubTime":"2026-10-12 20:32","pubTimestamp":1791808379,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MRNX","MRNY","IBBQ","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674865591","title":"美股异动 | 美国临床阶段生物制药公司Retension Pharmaceuticals(RTSN.US)登陆美股市场 开盘后股价跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674865591","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674865591?lang=zh_cn&edition=fundamental","pubTime":"2026-10-10 00:21","pubTimestamp":1791562908,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周五,Retension Pharmaceuticals(RTSN.US)登陆美股市场,截至发稿,该股跌超10%,报10.77美元。IPO价格为12美元。Retension Pharmaceuticals是一家美国临床阶段生物制药公司,专注于开发治疗高血压及其他心血管疾病的创新药物。公司的核心在研药物RTN-001是一款新一代磷酸二酯酶5(PDE5)抑制剂,主要针对血压未得到有效控制及难治性高血压患者,目前正开展IIb期临床试验。该药物通过增强血管中的一氧化氮信号传导,帮助血管舒张、降低血压,其全球独家开发许可来自法国制药巨头赛诺菲安万特(SNY.US)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505512.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MRNX","IBBQ","BK1610","RTSN","03069","MRNY","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673269660","title":"韩国1至9月生物制药出口额创纪录,达66亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673269660","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673269660?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 14:43","pubTimestamp":1791441821,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MRNX","BBP","IBBQ","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673026902","title":"韩国1至9月生物制药出口额创纪录,达66亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673026902","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673026902?lang=zh_cn&edition=fundamental","pubTime":"2026-10-08 14:43","pubTimestamp":1791441780,"startTime":"0","endTime":"0","summary":"韩国食品药品安全部周四公布政府数据显示,受欧洲市场旺盛需求拉动,今年前9个月韩国生物制药产品出口额创下66亿美元的新高。1–9月,韩国生物制药出口额同比增长15.8%,预估达66亿美元。该数据显示,这一部分出口额约占同期韩国医药产品总出口额90亿美元的73%。仅第三季度,生物制药出口额同比上涨15.6%,至20.7亿美元。前9个月,美国为韩国第一大出口目的地,出口规模10.7亿美元,占生物制药出口总额的16.3%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-10-08/doc-iniunvxc7651050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MRNY","IBBQ","03069","BK1610","BBP","MRNX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":16,"pageCount":1,"totalSize":63,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BBP\",params:#limit:6,delay:false,,,undefined,":[]}}